MedTrace Logo

Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells

NCT05186883 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-01-13

No results posted yet for this study

Summary

The idea of the project is to develop a method of treatment of postoperative hypoparathyroidism using cultured allogenic parathyroid cells.

Conditions

  • Postoperative Hypoparathyroidism

Interventions

BIOLOGICAL

Allogenic parathyroid cells

Allogenic parathyroid cells

OTHER

Standard treatment according to the Clinical protocols

Standard treatment of postoperative hypoparathyroidism according to the Clinical protocols

Sponsors & Collaborators

  • Belarusian State Medical University

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Andrei Hancharou, Dr · the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

  • Stanislav Treatiak, Prof · Belarusian State Medical University

  • Andrei Bolshov, Dr · Belarusian State Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05186883 on ClinicalTrials.gov